Has Antonio Sotomayor received payments from drug or device companies?

Yes. Drug and device makers reported $10,063 in general payments to Antonio Sotomayor across 420 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Antonio Sotomayor did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Antonio Sotomayor come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Antonio Sotomayor

Neurology · Reading, PANPI 1043321961

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.0% of the total across 420 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 56 manufacturers, the largest accounting for just 13.6% — the pattern of someone who eats at a lot of different presentations.

$10,063in general payments, 2019–2025

Across 420 payments — averaging $23.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
AstraZeneca$1K
Novo Nordisk$953
Boehringer Ingelheim$790
Lilly USA, LLC$708
Novartis$509
plus $5K from 50 others

What the payments were for

Speaking & faculty fees$190%
Food & beverage$9,95999%
Education$851%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	56	$1,365
AstraZeneca(2 entities)	32	$1,115
Novo Nordisk	41	$953
Boehringer Ingelheim	13	$790
Lilly USA, LLC	38	$708
Novartis	29	$509
Supernus Pharmaceuticals, Inc.	29	$434
Phathom Pharmaceuticals, Inc.	15	$355
Acadia Pharmaceuticals Inc	17	$281
Pfizer	5	$281
Sunovion Pharmaceuticals Inc.	13	$230
Amgen	10	$195
Teva Pharmaceuticals USA, Inc.	7	$174
TG Therapeutics, Inc.	3	$167
Biogen	7	$165
EMD Serono, Inc.	2	$161
UCB, Inc.	7	$160
Bayer	2	$150
Impel Pharmaceuticals Inc.	3	$146
Upsher-smith Laboratories LLC	7	$140
Kyowa Kirin, Inc.	6	$132
Amarin Pharma, Inc.	8	$124
Amneal Pharmaceuticals LLC	6	$110
Verona Pharma, Inc.	3	$92
MDD US Operations, LLC	4	$79
Otsuka America Pharmaceutical, Inc.	4	$72
Adamas Pharmaceuticals, Inc.	4	$60
Grifols USA, LLC	3	$57
Biohaven Pharmaceuticals, Inc.	2	$57
Vertical Pharmaceuticals, LLC	4	$53
Neurocrine Biosciences, Inc.	3	$52
GRT US Holding, Inc.	3	$50
Axsome Therapeutics, Inc.	2	$49
Biohaven Pharmaceutical Holding Company Ltd.	2	$46
Abbott	2	$44
Lundbeck LLC	2	$43
Livanova USA, Inc.	2	$40
Esperion Therapeutics, Inc.	2	$40
Acorda Therapeutics, Inc	2	$37
Medtronic	1	$35
Promius Pharma LLC	2	$33
SK Life Science, Inc.	2	$31
GE HealthCare	1	$25
Scilex Pharmaceuticals Inc.	1	$25
Merck	2	$24
Eisai Inc.	1	$20
GSK	1	$18
Catalyst Pharmaceuticals, Inc.	1	$17
Ironwood Pharmaceuticals, Inc	1	$17
Mallinckrodt Enterprises LLC	1	$16
Boston Scientific	1	$16
Nevro Corp.	1	$15
Sanofi	1	$15
Assertio Therapeutics, Inc.	1	$14
Neurelis, Inc.	1	$14
Johnson & Johnson	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,063 in reported general payments places this provider in the 75th percentile of 941 neurology providers in Pennsylvania.

See all neurology providers in Pennsylvania →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	68	$567
Carbidopa-LevodopaCarbidopa/Levodopa	43	$561
AmantadineAmantadine Hcl	12	$460
Propranolol Hcl	13	$198
Donepezil Hcl	27	$196

Paid to pharmacies, not to this prescriber.